<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS J</journal-id><journal-id journal-id-type="iso-abbrev">AAPS J</journal-id><journal-id journal-id-type="pmc-domain-id">792</journal-id><journal-id journal-id-type="pmc-domain">aapsj</journal-id><journal-title-group><journal-title>The AAPS Journal</journal-title></journal-title-group><issn pub-type="epub">1550-7416</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2751417</article-id><article-id pub-id-type="pmcid-ver">PMC2751417.1</article-id><article-id pub-id-type="pmcaid">2751417</article-id><article-id pub-id-type="pmcaiid">2751417</article-id><article-id pub-id-type="pmid">17907768</article-id><article-id pub-id-type="doi">10.1208/aapsj0902030</article-id><article-id pub-id-type="publisher-id">92268</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Pang</surname><given-names initials="KS">K. Sandy</given-names></name><address><phone>416-978-6164</phone><fax>416-978-8511</fax><email>ks.pang@utoronto.ca</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weiss</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Macheras</surname><given-names initials="P">Panos</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><aff id="Aff1"><label/>Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, M5S 3M2 Toronto, Ontario Canada </aff><aff id="Aff2"><label/>Section of Pharmacokinetics, Department of Pharmacology, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany </aff><aff id="Aff3"><label/>Laboratory of Biopharmaceutics-Pharmacokinetics, Faculty of Pharmacy, University of Athens, Athens, Greece </aff></contrib-group><pub-date pub-type="ppub"><month>6</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>29</day><month>6</month><year>2007</year></pub-date><volume>9</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">181899</issue-id><fpage>E268</fpage><lpage>E283</lpage><history><date date-type="received"><day>29</day><month>1</month><year>2007</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2007</year></date></history><pub-history><event event-type="pmc-release"><date><day>29</day><month>06</month><year>2008</year></date></event><event event-type="pmc-live"><date><day>14</day><month>10</month><year>2009</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-25 02:25:13.307"><day>25</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association of Pharmaceutical Scientists 2007</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12248_2008_Article_92268.pdf"/><abstract id="Abs1"><p>Three advanced models of pharmacokinetics are described. In the first class are physiologically based pharmacokinetic models based on in vitro data on transport and metabolism. The information is translated as transporter and enzyme activities and their attendant heterogeneities into liver and intestine models. Second are circulatory models based on transit time distribution and plasma concentration time curves. The third are fractal models for nonhomogeneous systems and non-Fickian processes are presented. The usefulness of these pharmacokinetic models, with examples. is compared.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Pharmacokinetic models</kwd><kwd>physiologically based pharmacokinetic</kwd><kwd>PBPK</kwd><kwd>models</kwd><kwd>liver</kwd><kwd>kidney</kwd><kwd>circulatory models</kwd><kwd>distribution</kwd><kwd>fractal models</kwd><kwd>homogeneous</kwd><kwd>nonhomogeneous</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; American Association of Pharmaceutical Scientists 2007</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>